LTRN
USDLantern Pharma Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$3.260
High
$3.510
Low
$3.020
Volume
0.09M
Company Fundamentals
Market Cap
36.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.13M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, will both be
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific antibody therapies, validating LP-284's mechanism of action. A novel differentiated
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ:LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development, today
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.